Abstract
Background and Objective: SARS-CoV-2 is the virus causing COVID-19, which is a potentially fatal illness. COVID-19 is a severe worldwide public health pandemic, because of its high fatality rate, quick transmission and lack of treatments. This work was carried out to assess the in silico inhibitory effect of phytocompounds from Balanites aegyptiaca on COVID-19. Materials and Methods: In this study Balanites aegyptiaca active compounds were screened for their potential activity on the main protease of SARS-CoV-2 using molecular docking and Molecular Dynamic (MD) simulation studies. Results: Precose compound showed the best docking energy (-9 kcal mol-1), the best stable complex with the main protease of SARS-CoV-2, MD simulation and stable integration of key residues (His41, Glu166 and Asp189) of the main protease active sites with Precose. Conclusion: These findings suggest that this compound could be a good candidate for developing and manufacturing an anti-SARS-CoV-2 medication.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
